Kalamazoo, Mich.-based Stryker is extending the range of its settlement program to include patients who underwent procedures to remove the recalled implants since Nov. 3, 2014.
Here's what you should know.
1. Several hundreds of people will be able to obtain compensation for the removal of the recalled Rejuvenate and ABGII modular hip implants.
2. The implants recalled in 2012 had a high failure rate associated with metallic corrosion. The related debris was causing tissue and muscle damage requiring complex revision surgeries.
3. The current settlement program is for litigation in New Jersey and Minnesota as well as for individual cases.
More orthopedic/spinal device news:
Providence Medical Technology receives $10.5M new equity financing — 5 points
Stavros Vizirgianakis to lead Misonix as new president, CEO: 5 things to now
NuVasive US Commercial President Matthew Link sells 10.3k shares: 5 key points